Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Summary of Stock Option Activity (Details)

v3.20.2
Stock-Based Compensation - Summary of Stock Option Activity (Details)
 9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Share-based Payment Arrangement [Abstract]  
Number of Options, Outstanding, Beginning Balance | shares 2,486,365
Number of Options Outstanding, Granted | shares 3,315,984
Number of Options Outstanding, Exercised | shares
Number of Options Outstanding, Forfeited | shares (1,000)
Number of Options Outstanding, Ending Balance | shares 5,801,349
Number of Options Outstanding, Exercisable Ending Balance | shares 4,086,855
Weighted Average Exercise Price, Beginning Balance | $ / shares $ 1.47
Weighted Average Exercise Price, Granted | $ / shares 0.50
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Exercise Price, Forfeited | $ / shares 100.00
Weighted Average Exercise Price, Ending Balance | $ / shares 0.90
Weighted Average Exercise Price, Exercisable Ending Balance | $ / shares $ 1.06
Weighted Average Contractual Term, Outstanding Beginning 8 years 8 months 2 days
Weighted Average Contractual Term, Outstanding Ending 8 years 9 months 7 days
Weighted Average Contractual Term, Exercisable Ending 8 years 6 months 7 days
Aggregate Intrinsic Value Outstanding, Beginning | $ $ 22,229 [1]
Aggregate Intrinsic Value Outstanding, Ending | $ 434,243 [1]
Aggregate Intrinsic Value Exercisable, Ending | $ $ 200,871 [1]
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our common stock as of December 31, 2019 and September 30, 2020, respectively.